Notably , the incidence of hypoglycaemia was higher with glimepiride than with linagliptin in each quartile of HbA1c change from baseline ( all p < 0.0001 ) ; the incidence of hypoglycaemic episodes was not increased with greater reductions in HbA1c in either group .